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Abstract
Cyclic paroxysm and high fever are hallmarks of malaria and are associated with high levels of pyrogenic cytokines,
including IL-1b. In this report, we describe a signature for the expression of inflammasome-related genes and caspase-1
activation in malaria. Indeed, when we infected mice, Plasmodium infection was sufficient to promote MyD88-mediated
caspase-1 activation, dependent on IFN-c-priming and the expression of inflammasome components ASC, P2X7R, NLRP3
and/or NLRP12. Pro-IL-1b expression required a second stimulation with LPS and was also dependent on IFN-c-priming and
functional TNFR1. As a consequence of Plasmodium-induced caspase-1 activation, mice produced extremely high levels of
IL-1b upon a second microbial stimulus, and became hypersensitive to septic shock. Therapeutic intervention with IL-1
receptor antagonist prevented bacterial-induced lethality in rodents. Similar to mice, we observed a significantly increased
frequency of circulating CD14+CD162Caspase-1+ and CD14dimCD16+Caspase-1+ monocytes in peripheral blood
mononuclear cells from febrile malaria patients. These cells readily produced large amounts of IL-1b after stimulation
with LPS. Furthermore, we observed the presence of inflammasome complexes in monocytes from malaria patients
containing either NLRP3 or NLRP12 pyroptosomes. We conclude that NLRP12/NLRP3-dependent activation of caspase-1 is
likely to be a key event in mediating systemic production of IL-1b and hypersensitivity to secondary bacterial infection
during malaria.
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Introduction
Every year, approximately 250 million people are infected with
Plasmodium, contributing to significant social and economic
instability in the developing countries around the world [1]. One
of the main physiological responses to Plasmodium infection is the
paroxysm – characterized by cycles of sharp peaks of high fever
accompanied by chills and rigors, which coincide with the release
of parasites from synchronized infected red blood cells [2,3].
Parasite components, such as DNA bound to hemozoin [4,5] and
glycosylphosphatidylinositol (GPI) anchors [6], trigger the pro-
duction of proinflammatory cytokines, including interleukin-1 beta
(IL-1b), via activation of Toll-Like receptors (TLRs) [7]. Further-
more, malaria sepsis [8] leads to an exquisite sensitivity to
secondary bacterial infections, in particular non-typhoidal salmo-
nellosis, that often associate with severe disease [9–12]. Hence, a
better understanding of the mechanisms involved on this
inflammatory stage during malaria is critical for the clinical
management and prevention of severe disease.
TLRs are only one family of the receptors required for the
release of active IL-1b, as cleavage of pro-IL-1b by caspase-1 also
requires activation of Nod-Like Receptors (NLRs) [13,14]. Upon
stimulation, the respective NLRs oligomerize and recruit pro-
caspase-1 directly via a N-terminal caspase recruitment domain
(CARD) homotypic interaction (CARD-CARD) (e.g., CARD-
containing NLRs such as NLRP1 or NLRC4) or indirectly via the
adaptor molecule called apoptosis-associated speck-like protein
containing a caspase recruitment domain (ASC), as is the case of
NLRP3-inflammasome [13]. The inflammasome assembly culmi-
nates on activation of caspase-1, and consequent release of the
active form of IL-1b. NLRP3 containing inflammasome is
activated in response to a large range of insults, such as pathogens,
bacterial RNA, and crystal structures [15–17]. The NLRP12 was
the first NLR shown to associate with ASC and to form an active
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IL-1b-maturing inflammasome [18]. This receptor was initially
placed as a negative regulator of inflammation [19,20], but it was
also shown to be involved in periodic fever of cryopyrinopathies
[21], and to mediate host resistance to Yersinia pestis [22].
Here, we asked what are the molecular steps required for and
the physiological role of inflammasome assembly during malaria
sepsis. Our results indicate that symptomatic Plasmodium infection
triggers inflammasome formation and caspase-1 activation via an
intricate process that requires several inflammatory mediators as
well as NLRP3 and NLRP12. Furthermore, we found that the
malaria-primed monocytic cells produce deleterious amounts of
IL-1b when exposed to a second microbial challenge, being an
important component of the overwhelming inflammatory response
observed during bacterial superinfection.
Results
Expression of inflammasome genes and ASC-dependent
caspase-1 activation in rodent malaria
The Plasmodium chabaudi AS rodent model was used to evaluate
the in vivo activation of inflammasome. The microarray analysis of
splenocytes from C57BL/6 at 6 days post-infection demonstrates
enhanced expression of various genes from the inflammasome
pathway, including Casp1 and Il1b (Figure 1A). Consistently, the
FLICA assay, which employs the fluorescent probe FAM-YVAD-
FMK and Western blot, indicate that infection with P. chabaudi is
sufficient to promote caspase-1 activation (Figures S1A and 1B).
Immunoblots evidenced enhanced expression and cleavage of pro-
caspase-1 in spleens from P. chabaudi infected mice (Figures S1B,
S1C and 1C). The FLICA assay also revealed that macrophages
(CD11b+F4/80+) and dendritic cells (DCs) (CD11c+MHC-II+) are
the main source of active caspase-1 (Figure 1B) in the spleens
from infected mice. We also observed a high frequency of
macrophages and DCs undergoing inflammatory cell death
(pyroptosis), as defined by damage of cell membranes evaluated
by DNA-7AAD staining and augmented cell size associated with
active caspase-1 (Figure 1B). Other splenic cell subsets did not
express active caspase-1 or were undergoing pyroptosis during P.
chabaudi infection (Figure S1D).
Importantly, macrophages and DCs from mice deficient for Asc
(ASC2/2) and Casp1 (Casp-12/2) were negative for both active
caspase-1 and pyroptosis markers during P. chabaudi infection
(Figures 1B). Similar results were obtained when we used
splenocyte lysates in immunoblots to detect active caspase-1
(Figures 1C). We also evaluated the role of caspase-1 activation
in host resistance to P. chabaudi. C57BL/6, ASC2/2 and Casp-12/
2 mice injected with 105 P. chabaudi infected erythrocytes displayed
similar parasitemia beginning at day 5, peaking at days 7–8 days,
and completely resolved at 25 days post-infection (Figure S2A).
No lethality was observed until the end of the experiment.
Leuckocytes from mice and humans infected with Plasmodium
are hyper-responsive to TLR agonists [23]. This hyperresponsive-
ness does not occur at all phases of infection. For example, as we
show in Figure S2B, mice that are infected with P. chabaudi were
hyperresponsive to small doses of TLR ligands, such as
lipopolysaccharide (LPS), during the acute phase of the disease
(day 7). This hyperresponsiveness was no longer observed when
mice were challenged with low dose LPS 4 weeks after infection.
Based on this and other studies [24,25], we hypothesize that
bacterial superinfection is a common co-factor for severe malaria.
Thus, we used a challenge with low dose of bacterial LPS to mimic
secondary bacterial infection and to evaluate the role of
inflammasome and IL-1b in this process. C57BL/6 mice infected
with P. chabaudi produced low, but significant levels of IL-1b, when
compared to uninfected controls (Figures 1D and S2B).
Surprisingly, these low levels of circulating IL-1b were produced
in an ASC and Caspase-1-independent manner (Figure 1D). In
contrast, production of IL-1b, which was extremely high in
infected C57BL/6 mice challenged with LPS, was severely
impaired in ASC2/2 or Casp-12/2 mice (Figure S2B and
Figure 1D). In order to check whether the active caspase-1+ cells
were the main sources of active IL-1b, highly purified CD11b+
and CD11c+ cells from infected mice were stimulated with LPS
and IL-1b measured thereafter. Both CD11b+ as well as CD11c+
cells produced high levels of IL-1b (Figure 1E).
MyD88-dependent expression of inflammasome genes
and caspase-1 activation in rodent malaria
The in vivo proinflammatory priming promoted by Plasmodium
infection is partially dependent on TLR9 activation by parasite
DNA [4,23,26]. Consistently, expression of various inflammasome
genes was no longer enhanced in Myd88-deficient mice (MyD882/
2) infected with P. chabaudi (Figure 1A and Table S1).
Accordingly, we did not observe active caspase-1, and pyroptotic
features in macrophages and DCs from MyD882/2 mice infected
with P. chabaudi (Figure 1C and 1F). As expected, no systemic IL-
1b was detected in sera of infected MyD882/2 mice challenged or
not with LPS (Figure 1G). Furthermore, the data presented in
Figure S3A show reduced expression of pro-caspase-1 in Tlr9-
deficient mice (TLR92/2). In view of this reduced level of basal
expression of the pro enzyme, it is not surprising that expression
levels of its active form were decreased in TLR92/2 mice infected
with P. chabaudi. Likewise, the levels of circulating IL-1b were
partially affected and survival rates increased in infected TLR92/
2 mice challenged with the low LPS dose (Figures S3B and
S3C). Finally, we found that priming with CpG immunostimu-
latory oligonucleotides mimics P. chabaudi infection leading to
enhanced susceptibility to LPS challenge, but does not induce
lethality when used to challenge P. chabaudi infected mice (Figure
S3D).
Author Summary
Together Plasmodium falciparum and P. vivax infect
approximately 250 million individuals, reaping life of near
one million children every year. Extensive research on
malaria pathogenesis has funneled into the consensus that
the clinical manifestations are often a consequence of the
systemic inflammation. Importantly, secondary bacterial
and viral infections potentiate this inflammatory reaction
being important co-factors for the development of severe
disease. One of the hallmarks of malaria syndrome is the
paroxysm, which is characterized by high fever associated
with peak of parasitemia. In this study we dissected the
mechanisms of induction and the importance of the
pyrogenic cytokine, IL-1b in the pathogenesis of malaria.
Our results demonstrate the critical role of the innate
immune receptors named Toll-Like Receptors and inflam-
masome on induction, processing and release of active
form of IL-1b during malaria. Importantly, we provide
evidences that bacterial superinfection further potentiates
the Plasmodium-induced systemic inflammation, leading
to the release of bulk amounts of IL-1b and severe disease.
Hence, this study uncovers new checkpoints that could be
targeted for preventing systemic inflammation and severe
malaria.
NLRP12/NLRP3 Inflammasomes in Malaria
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Figure 1. Caspase-1 activation, IL-1b production and pyroptosis in splenic macrophages and DCs from P. chabaudi infected mice. (A)
Gene expression was determined in splenocytes of 3 C57BL/6 or MyD882/2 mice at 6 days post-infection over 3 non-infected controls by Microarray
analysis. (B and F) Splenocytes from C57BL/6, ASC2/2, Casp-12/2 or MyD882/2 mice were stained and analyzed by FACs to gate macrophages
(CD11b+F4/80+) and DCs (CD11c+MHC-II+). Active caspase-1 was evaluated by FLICA reagent, membrane integrity by nuclei staining with 7AAD, and
cell size change by shift on FSC axis. The results are representative from 3 experiments that yield similar results. (C) On day 7 post-infection
splenocytes from C57BL/6, ASC2/2, Casp-12/2 and MyD882/2 mice were lysed by RIPA buffer and analyzed by Western blot employing an anti-
caspase-1 antibody. A faint band of similar molecular weight of active caspase-1 corresponds to IgG light chain is seen in the infected ASC2/2 and
Casp-12/2 mice. (D and G) At 7 days post-infection mice were inoculated intravenously with 10 mg of LPS per mouse, and 9 hours later, sera was
NLRP12/NLRP3 Inflammasomes in Malaria
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IFN-c is required for expression of pro-caspase-1 and pro-
IL-1b in rodent malaria
The levels of circulating interferon gamma (IFN-c), tumor
necrosis factor-alpha (TNF-a) and IL-1b in sera of P. chabaudi
infected mice, challenged or not with LPS, are presented in
Figure S2B. Very low levels of IFN-c, TNF-a, and IL-1b were
detected in sera from uninfected mice challenged with low dose
LPS. The hyperresponsiveness to LPS was observed in the first two
weeks, but not at 28 days post-infection (Figure S2B). IFN-c was
shown to be a key mediator of inflammatory priming in febrile
malaria patients and in mice infected with P. chabaudi [23].
Furthermore, TNF-a, a critical cytokine in malaria pathogenesis
[27,28] was shown to mediate expression of inflammasome
components and pro-IL-1b [29,30]. Indeed, even upon LPS
challenge, active IL-1b was not produced in either Ifng or Tnfrsf1a-
deficient mice (IFN-c2/2) and (TNFR12/2) respectively, when
infected with P. chabaudi (Figure 2A). Normal activation of
caspase-1 was observed in macrophages and DCs from TNFR12/
2, but not from IFN-c2/2 mice (Figures 2B, 2C and S4). In
contrast, both IFN-c and TNF-a were required for expression of
pro-IL-1b by spleen cells of infected mice challenged with LPS
(Figures 2D and S4).
NLRP3 and NLRP12 are required for caspase-1 activation
and optimum IL-1b production during rodent malaria
We next evaluated the requirement of specific NLRs for
caspase-1 activation. The P2X7 receptor (P2X7R) which senses
extracellular ATP, opens a cation-specific channel that alters the
ionic environment of the cell [31] culminating on NLRP3-
inflammasome assembly under certain conditions [32,33]. Here
we found that P2X7R is necessary for caspase-1 activation during
in vivo infection with P. chabaudi (Figure 3A). Consistently, NLRP3
and NLRP12 were required for activation of caspase-1, systemic
production of IL-1b and pyroptosis (Figures 3B, 3C and 3D).
Other cytosolic receptors, i.e. NLRC4 and absent in melanoma 2
(AIM2) were not essential for IL-1b release (Figure 3D). The
levels of circulating IL-1b in sera of C57BL6, NLRP32/2,
NLRP122/2, ASC2/2 as well as Casp-12/2 infected mice, but no
challenged with LPS, were not statically different (Figure 3D).
Therapeutic effects of IL-1 receptor antagonist in rodent
malaria
The infected Il1r-deficient mice (IL-1R2/2) mice are partially
resistant to the LPS challenge, despite of the sustained levels of
active caspase-1, IL-1b and TNF-a (Figures 4A and 4B).
Importantly, in the different mouse lineages infected with P.
chabaudi, we observed a striking correlation of high circulating IL-
1b, but not necessarily active caspase-1, and lethality induced by
LPS (Table 1 and Figure 3D). Consistently, treatment with IL-1
receptor antagonist (IL-1RA) prevented lethality of P. chabaudi
infected mice challenged with LPS (Figure 4C).
These results were validated in P. chabaudi infected mice
challenged with sub-lethal cecal ligation puncture (CLP)
(Figure 4D), a classic model for bacterial sepsis, as well as
peroral infection with Salmonella typhimurium (Figure 4E). In both
cases, bacterial superinfection leaded to rapid lethality that was
associated with high circulating levels of IL-1b. Furthermore,
mortality of co-infected mice was delayed or prevented by
treatment with the IL-1RA. The loads of bacteria translocation
were similar in co-infected mice treated or not with IL-1RA
(Figures 4F and 4G).
Increased frequency of pyroptotic
CD14dimCD16+Caspase-1+ monocytes in PBMCs from
symptomatic malaria patients
We next studied caspase-1 activation and IL-1b release in
peripheral blood mononuclear cells (PBMCs) from patients
undergoing febrile malaria. Two different subsets of monocytes
were closely examined: CD14+CD162 or CD14dimCD16+ mono-
cytes (Figure 5A and S5A). Active caspase-1 was constitutively
expressed in CD14+CD162 cells from healthy individuals, as
previously described [34]. Nevertheless, the frequency of
CD14+CD162 cells was augmented on average 3 fold in P. vivax
malaria patients. The frequency and intensity of caspase-1
expression, indicated by median fluorescence intensity (MFI), in
different monocyte subsets from healthy and P. vivax infected
individuals before and after treatment are shown in Figure 5A.
Expression of active caspase-1 in association with membrane
damage and augmented cell size was also observed in
CD14dimCD16+ monocytes (Figure S5A). The representative
histograms presented in Figure S5A were obtained from counter
plot gates shown in Figure 5A and illustrate the results for active
caspase-1, membrane damage and cell size change from one
malaria patient before and after treatment, and a healthy donor.
Other cell populations found in PBMCs were negative for active
caspase-1 and pyroptosis markers (Figure S5B).
We also observed increased cleavage of caspase-1 (p10) in
PBMCs from either P. vivax or P. falciparum malaria patients
(Figures 5B, 5C and S5C). In addition, LPS-induced release of
IL-1b is highly augmented in PBMCs from the same patients
undergoing malaria sepsis (Figure 5B and 5C – bottom
panels). Furthermore, we observed enhanced expression of
inflammasome genes in PBMCs from P. falciparum malaria patients
(Figure S5D and Table S2). As observed in the rodent malaria
model (Figure 2), IFN-c-priming of primary human monocytes
mimics in vivo infection with Plasmodium and augments expression
of pro-caspase-1, pro-IL-1b as well as IL-1b release induced by
LPS stimulation (Figure S5E).
NLRP12/NLRP3 containing inflammasomes in febrile P.
vivax infected patients
The nature of malaria-induced inflammasome was further
explored by performing a crosslinking assay and confocal analyses.
We observed an augmented multimerization of ASC (Figure 6A) in
PBMCs from P. vivax infected individuals. Additionally, confocal
microscopy indicated that inflammasome specks contained either
NLRP3 (green) or NLRP12 (red), were present in 7 and 10% of
monocytes from P. vivax malaria patients, respectively (Figure 6B
and 6C). There was no co-localization of NLRP3 and NLRP12
specks. We did not detect monocytes containing NLRC4-inflamma-
some, and AIM2 specks appeared in a low frequency, ,0.25% of
monocytes from infected individuals. No specks were detected in
collected for measuring the levels of circulating IL-1b. The average levels of IL-1b in control and infected mice, before LPS challenge, were 64.2 and
434.2 pg/ml in figure D, and 82.2 and 602.4 pg/ml in figure G. These results are the means + SEM of 10–15 animals from 3 independent experiments
that yield similar results. (E) CD11c+ and CD11b+ cells highly purified from spleens of C57BL/6 mice at day post-infection were cultured with LPS
(1 mg/ml) and supernatants harvested 18 h later to measure the levels of IL-1b. As positive control we used the purified cells stimulated with LPS at
same concentration followed by nigericin at 5 mM. Significant differences are indicated by *p,0.01, **p,0.001 and ***p,0.0005 obtained in the
Mann-Whitney test.
doi:10.1371/journal.ppat.1003885.g001
NLRP12/NLRP3 Inflammasomes in Malaria
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monocytes from uninfected healthy donors (Figure 6C). Figure S6
provides controls of the confocal analysis.
Discussion
Paroxysm, an acute fever accompanied by chills and rigors, is a
hallmark of Plasmodium infection [3,35]. While the physiological
role of fever is controversial, it can aid in host defense, delaying the
growth of pathogens with strict temperature preferences [36]. In
fact, prior to the discovery of antibiotics, deliberate infection with
P. vivax was used to induce high fever and eliminate infection with
Treponema pallidum in neurosyphilis patients [37]. However, fever is
also associated with various pathological processes, such as
respiratory distress, anemia, and neurological manifestations that
cause morbidity and mortality in malaria [3,35]. These clinical
manifestations are related to the intensity of the systemic
inflammatory response, yet the basic details of malaria-induced
cytokinemia are not understood. Overall, our results indicate that
Plasmodium infection primes innate immune cells leading to the
oligomerization of inflammasomes containing, ASC, NLRP3 and
NLRP12, resulting in activation of caspase-1 and the production
of copious amounts of IL-1b upon a second TLR activation. An
immediate consequence of this inflammatory priming is a drastic
reduction in the threshold to septic shock-like syndrome caused by
secondary bacterial infection.
Although there is a controversy about the role of different TLRs
in the pathogenesis of malaria [38–41], various studies indicate
that the initial cytokine storm during malaria is driven by TLR
activation. Initial studies suggested that GPI anchors were the
main P. falciparum molecules responsible for eliciting the produc-
tion of proinflammatory cytokines during malaria [6]. However,
recent studies indicate that parasite derived DNA containing both
immunostimulatory CpG and AT-rich motifs, is instead the main
force driving the cytokine storm during malaria sepsis [4,5,42].
Indeed, mice bearing non-functional TLR9 or MyD88, or treated
with a TLR7/TLR9 antagonist display a less pronounced
Figure 2. Both endogenous IFN-c and TNF-a are required for IL-1b production in mice infected with P. chabaudi. (A) Mice were
challenged with 10 mg of LPS, at 7 days post-infection, and sera collected 9 hours later for cytokine measurements. These results are means + SEM of
10 animals from 2 independent experiments. Significant differences are *p = 0.034 and **p = 0.001 as indicated by the Mann-Whitney test. (B) Active
caspase-1, membrane integrity and cell size were assessed in macrophages (CD11b+F4/80+) and DCs (CD11c+MHC-II+) by flow cytometry, employing
the FLICA reagent, nuclei staining with 7AAD, and the shift on FSC axis, respectively. These results presented in figures are representative of 2
experiments. (C) Splenocytes lysates were obtained from mice at 7 days post-infection and used in Western blot analysis. A faint band of similar
molecular weight of active caspase-1 that corresponds to IgG light chain is seen in the uninfected controls or infected IFN-c2/2 mice. These results
presented in figures are representative of 2 experiments. (D) Two hours after LPS-challenge, splenocytes lysates were harvested to evaluate
expression of pro-IL-1b. These results are representative of 3 independent experiment that yielded similar results.
doi:10.1371/journal.ppat.1003885.g002
NLRP12/NLRP3 Inflammasomes in Malaria
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inflammatory response and attenuated pathology during experi-
mental malaria [23,26,38,41]. Moreover, mutations in TLR2,
TLR9 and Mal/TIRAP appear to affect the outcome of human
disease [24,25,43,44].
Importantly, infection with Plasmodium in humans leads to a
proinflammatory priming and hyperresponsiveness to microbial
products [23,45–47]. This enhanced ability to respond to microbes
during immunosurveillance protects the host against infectious
insult, but the innate immune response is the classic ‘‘double-
edged sword’’. Thus, the proinflammatory priming means that the
innate immune system can overreact to secondary infection,
leading to a septic shock syndrome with clinical manifestations. It
is noteworthy that malaria is often associated with bacterial
infections [12]. Furthermore, a recent study highlights that the
chance to develop severe malaria is elevated 8.5 fold in children
with bacteremia [9]. Similarly, bacterial and viral infections may
also act as co-factors for severe P. vivax malaria [10,35,48]. We
propose that inflammasome and IL-1b [35,49,50] are important
components of the proinflammatory priming and the exquisite
sensitivity to superinfection during malaria.
Here, we demonstrate that both in mouse and human malaria
expression of inflammasome genes, caspase-1 activation and
pyroptosis are induced in phagocytic cells. As a consequence,
during Plasmodium infection the threshold for LPS sensitivity is
decreased in at least 100 folds, as compared to non-infected
control mice [51,52]. Previous studies have shown that 1.0 mg of
LPS induces the production of high IL-1b levels and lethality
[52,53]. In our model, challenge with 10 mg of LPS did not
promoted or augmented caspase-1 activation in either uninfected
or infected mice, respectively. Hence, Plasmodium infection is
sufficient to induce inflammasome assembly and caspase-1
activation, but requires a challenge with a low dose of LPS to
induce expression of pro-IL-1b and release of high levels of its
active form.
Our studies in the P. chabaudi mouse model demonstrate that
expression of inflammasome genes; pro-caspase-1 as well as pro-
IL-1b are all dependent on intact Myd88 function. The MyD88
role on the process is independent of the IL-1 receptor signaling, as
macrophages and DCs from P. chabaudi-infected IL-1R2/2 mice
show normal levels of caspase-1 activation and pyroptosis. In fact,
we found that TLR9 explains, in part, the role of MyD88 on
caspase-1 activation. As previously reported [54], treatment with
CpG oligonucleotides mimics the P. chabaudi infection making the
mice more susceptible to septic shock. Curiously, challenge of
infected mice with CpG oligonucleotides did not result in lethality.
As CpG DNA and LPS preferentially target DCs and monocyte/
macrophages, respectively [55], our data suggest that the nature of
the ligand and differential expression of TLRs are important
determinants on priming and cytokine production by Plasmodium
infected mice challenged with LPS.
We hypothesize that by targeting TLR9 on DCs, Plasmodium infec-
tion elicits the IL-12 production, and consequent IFN-c-dependent
Figure 3. NLRP3/NLRP12-dependent activation of caspase-1 and pyroptosis in mice infected with P. chabaudi. (A) At 9 days post-
infection, splenocytes from C57BL/6, and P2X7R2/2 mice were lysed and analyzed by Western blot employing caspase-1-specific antibody. (B) At 7
days post-infection, active caspase-1 by FLICA reagent, membrane integrity by propidium iodide, and cell size change by shift on FSC axis were
assessed in splenic macrophages (CD11b+F4/80+) and DCs (CD11c+MHC-II+). (C) Splenocytes lysates from mice at 7 days post-infection were used to
detected active caspase-1 by Western blot. A faint band of similar molecular weight of active caspase-1 that corresponds to IgG light chain is seen in
the uninfected controls or in various infected knockout mice. The results presented in figures 3A, 3B and 3C are representative of 2 experiments that
yield similar results. (D) A LPS dose of 10 mg/mouse was given intravenously at 7 days post-infection with P.chabaudi and sera collected 9 hours later,
for measuring IL-1b and TNF-a levels. The numbers within parenthesis indicate the percentage of lethality 48 hours after LPS challenge (10 mg/
mouse). The levels of IL-1b measured in the sera of infected C57BL/6, NLRP32/2, NLRP12, ASC2/2 and Casp-12/2 were not different. The results are
means + SEM of 10 mice from 2 independent experiments. Significant differences are indicated by **p,0.001 obtained in the Mann-Whitney test.
doi:10.1371/journal.ppat.1003885.g003
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inflammatory priming [23]. Priming with IFN-c mediates caspase-1
activation through the induction of pro-caspase-1 expression, and the
lack of either IFN-c or TNFR1 results in impaired expression of pro-
IL-1b. Hence, LPS, but not CpG, stimulates the production of high
levels of TNF-a and pro-IL-1b culminating on the release of
deleterious amounts of active IL-1b by IFN-c-primed monocytes/
macrophages. An alternative explanation is that by inducing Type I
IFN production by DCs, Plasmodium infection inhibits the excessive
production of IL-1b [56,57], and prevents lethality induced by TLR9
activation.
Another important requirement for caspase-1 activation in
rodent malaria was the purinergic P2X7 receptor that under
certain conditions mediates NLRP3-inflammasome activation
[32,58]. Indeed, in vitro experiments reported that synthetic
hemozoin induces inflammasome formation, activation of cas-
pase-1 and release of IL-1b by macrophages via NLRP3 [59–62].
Here, we demonstrated an in vivo requirement of both NLRP3 and
NLRP12 for inflammasome formation and caspase-1 activation
during in vivo infection with P. chabaudi. We also report that
symptomatic infection with either P. falciparum or P. vivax leads to
enhanced expression of inflammasome related genes and caspase-
1 activation. Notably, we notice an in vivo assembly of NLRP3 and
NLRP12 specks and ASC oligomerization in febrile malaria
patients. A diagram detailing the different steps required for
inflammasome assembly during malaria sepsis, and release of
copious amounts of IL-1b during bacterial superinfection is
presented in Figure 7.
It is noteworthy that periodic fever is a main symptom of
cryopyrinopathies, a human inflammatory disorder that is
associated with mutations in both NLRP3 and NLRP12 genes
[21]. These patients have less severe symptoms when treated with
IL-1R antagonist [63]. However, the relevance of this process
during in vivo Plasmodium infection is controversial. While Dostert
and colleagues [59] demonstrated a partial protection to
experimental cerebral malaria in NLRP32/2 mice, other studies
reported that this pathological process occurs independent of
NLRP3, ASC, Caspase-1, IL-1R, IL-1b, and IL-18 [62,64].
Furthermore, a study in the P. chabaudi model shows that caspase-
12 (but not caspase-1), modulates cytokine responses and
development of acquired immunity [65]. Thus, our results indicate
Figure 4. Treatment with IL-1RA prevents lethality in mice infected with P. chabaudi and challenged with a secondary bacterial
infection. (A) At 7 days post-infection, mice were challenged with 10 mg of LPS and serum samples collected 9 hours later for cytokine
measurements. The numbers within parenthesis indicate the percentage of lethality 24 hours after low dose (10 mg/mouse) LPS challenge. (B) Splenic
macrophages (CD11b+F4/80+) and DCs (CD11c+MHC-II+) from mice at 7 days post-infection were stained with FLICA reagent in order to detect active
caspase-1. (C) At day 7 post-infection the mice were treated with IL-1RA (anakinra) immediately prior to LPS challenge. Lethality was assessed from 12
to 48 hours post-LPS challenge. (D) At 7 days post-infection with P. chabaudi, sub-lethal sepsis was induced by CLP. A group of mice received
treatment with IL-1RA (100 mg/kg/day) beginning 24 hours before the CLP procedure. Levels of circulating IL-1b were measured 24 hs after CLP. (E)
Mice received peroral challenge with 108 of Salmonella typhimurium at 5 days post-infection with P. chabaudi. A group of mice received treatment
with IL-1RA (100 mg/kg/day) beginning 48 hours after bacterial challenge. The levels of circulating IL-1b were measured at 3 days post-Salmonella
challenge. (F) Translocation of aerobic bacteria was quantified 24 hours after the CLP procedure. (G) Translocation of S. typhimurium was quantified 3
days after peroral challenge. We used 5 to 8 mice per group and results shown are representative of 2 independent experiments. Significant
differences are *p,0.01, **p,0.005 ***p,0.001 obtained in a Chi-square test.
doi:10.1371/journal.ppat.1003885.g004
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that bacterial superinfection overcome the regulatory role of
caspase 12.
Our results demonstrate that P. chabaudi infection triggers low
levels of IL-1b release in an inflammasome-independent manner.
Nevertheless, the parasite-induced NLRP3 and NLRP12 inflam-
masomes play a key role in the release of high IL-1b levels and
hypersensitivity to LPS during malaria sepsis. Importantly, the
lethality induced by low dose LPS, peroral infection with S.
typhimurium, or sublethal CLP in P. chabaudi infected mice was
prevented or delayed by treatment with IL-1R antagonist.
Relevant to our findings is the recently published study
demonstrating that malaria impairs host resistance to Salmonella
infection [11]. They propose that induction of heme oxygenase21
(HO-1) by Plasmodium infection limits the generation of reactive
oxygen species (ROS), an important mechanism of host resistance
to Salmonella infection [66]. Another consequence of the decreased
ROS generation during malaria would be the uncontrolled
activation of caspase-1 and release copious amounts of active IL-
1b by phagocytes, as previously reported in patients with chronic
granulomatous disease (CGD) [67–69].
Similarly to murine malaria, extremely high levels of IL-1b are
produced by PBMCs from P. vivax or P. falciparum malaria patients
exposed to bacterial components [23,47]. Importantly, the
bacterial load in mice undergoing malaria sepsis was not different
from mice treated with IL-1RA, suggesting that the acute lethality
caused by bacterial superinfection is due to the deleterious
inflammatory response. Overall, our data argue that the IFN-c,
TNF-a and MyD88 role on hypersensitivity to septic shock during
malaria is, at least in part, mediated by inflammasome-dependent
release of IL-1b.
In conclusion, years of research on malaria pathogenesis have
funneled into the consensus that the clinical manifestations are
often a result of the excessive activation of the innate immune cells.
Recent reports have emphasized the important role of bacterial
infections as co-factors for severe disease. Here we report that
Plasmodium-induced NLRP3, NLRP12, ASC containing inflam-
masomes and caspase-1 activation, which are important events for
the overwhelming IL-1b response and morbidity observed in
bacterial superinfection during malaria sepsis.
Materials and Methods
Ethics statement
The study with Plasmodium infected patients and healthy
controls was approved by the Ethical Committee of Research
(CEP) from the Research Center of Tropical Medicine (CEP-
CEPEM 096/09); the Brazilian National Committee of Research
(CONEP/Ministry of Health – 15653); as well as the Institutional
Research Board from the University of Massachusetts Medical
School (UMMS) (IRB-ID11116_1). Informed written consent was
obtained before enrollment of all subjects (Plasmodium infected
patients and healthy control). All experiments involving animals
were in accordance with guidelines set forth by the American
Association for Laboratory Animal Science (AALAS) and with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the Brazilian National Council of Animal
Experimentation (http://www.cobea.org.br/) and the Federal
Law 11.794 (October 8, 2008). All protocols developed for this
work were approved by the Institutional Animal Care and Use
Committee (IACUC) at the UMMS (ID - 2371-12), (ID - 1369-
11) and also were approved by the Council of Animal
Experimentation of Oswaldo Cruz Foundation (CEUA protocol
38/10-3).
Table 1. Association of circulating IL-1b levels and high susceptibility to endotoxic shock in mice primed by infection with
P.chabaudi.
Mice
Number of mice
tested Parasitemia(%) Survival(%)
Active casp-1 MFI
(61000)
IL-1b levels
(ng/ml)
Survival - Fischer’s
exact test wild type vs
knockout mice
C57BL/6 (wild type mice)
Uninfected control 15 - 100 1.5760.17 0.35
P.chabaudi infected 30 16 0 4.2160.64 6.36
Mice deficient in TLR adaptor molecule and infected with P.chabaudi
MyD882/2 5 19 100 1.2360.13 0.25 p,0.0001
Mice deficient in cytokine or in cytokine receptors and infected with P.chabaudi
IFN-c 2/2 12 23 100 1.2960.11 0.31 p,0.0001
TNFR12/2 12 20 100 3.6560.49 0.23 p,0.0001
IL-1R2/2 10 18.5 60 3.8960.15 5.40 p= 0.0012
Mice deficient in inflammasome components s and infected with P.chabaudi
ASC2/2 8 17 78.5 1.1260.23 0.47 p = 0.0003
Casp-12/2 9 16 66.6 1.2560.17 1.27 p = 0.0006
NLRP32/2 10 17 70 1.1860.27 2.61 p = 0.0002
NLRP122/2 5 17.5 60 1.2860.36 1.89 p = 0.0088
AIM22/2 5 18 0 4.1960.42 5.49 p = 1.00
NLRC42/2 (Ipaf2/2) 4 14.5 0 3.9360.32 4.38 p = 1.00
IL-1b release and high susceptibility to endotoxic shock. Mice were infected with 105 parasitized red blood cells (i.p). At 7 days post-infection, a low dose LPS (10 mg/
mouse) was inoculated and lethality evaluated 24 hours later. Parasitemia was defined by smears giemsa- stained. FLICA reagent was used to assess active caspase-1 in
total splenocytes from mice at 7 days post-infection. The data were collected by flow cytometry and median fluorescence intensity (MFI) analyses performed using
Flowjo software. The range of detection of circulating IL-1b was 15.6–1000 pg/ml and determined using and ELISA Duoset kit from R&D Systems.
doi:10.1371/journal.ppat.1003885.t001
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Reagents
LPS O55:B55 from E. coli, nigericin and RIPA buffer were
obtained from SIGMA. All mAbs used in flow cytometry, as well
as 7AAD and PI were purchased from Ebiosciences. Active
caspase-1 detection kit was obtained from ImmunoChemistry
Technologies, LLC (catalog no. 98). Human (SC-515) and mouse
(SC-514) anti-caspase-1 (p10), ASC (SC-22514-R and SC-271054)
primary antibodies were obtained from Santa Cruz Biotechnology
and anti-actin (A2066) was purchased from SIGMA. Anti-caspase-
1 (p20) was donated by Genentech. Anti-NLRP3 (ab4207 and
ab17267), -NLRP12 (ab64928 and ab57906), -NLRC4 (ab99860),
secondary Anti-rabbit IgG Texas Red (ab6800), secondary anti-
goat IgG Texas Red (ab6883), secondary anti-goat IgG FITC
(ab6881), and secondary anti-mouse IgG FITC (ab7057) were
purchased from Abcam. The secondary antibodies used in western
blots were purchased from KPL. Ficoll-Paque from GE Health-
care, and the crosslinker disuccinimidyl suberate [70] was
obtained from Thermo Scientific. Protease inhibitor (EDTA free)
was purchased from Roche and RPMI and DMEM from Gibco.
Cytokine ELISA kits and Cytometric Bead Array were obtained
from R&D Systems and BD Biosciences, respectively. Flow
cytometry mAbs for mouse were from BD Biosciences: CD11c-
PE (cat-557401), CD11b-PE (cat-557397), CD3-FITC (cat-
553062), B220-APC (cat-561880), and from Ebioscience: MHC-
II-PercpCy5 (cat-15-5321-82), and F4/80-APC (cat-17-4801-82),
CD4-PE (cat-12-0041), CD8-PE (cat-12-008-81), and NKG2d-PE
(cat-12-5872). Flow cytometry mAbs for human were from BD
Biosciences: CD16-FITC (cat-555969), CD14-APC (cat-561708),
CD19-FITC (cat-555412); and from Ebioscience: CD3-FITC (cat-
55332), CD4-PE-Cy5 (cat-555348), CD8-PE-Cy5 (cat-555368),
CD1c-APC (cat-17-0015), CD123-PercpCy5.5 (cat-45-1239),
CD303-FITC (cat-11-9818-42), CD56-PE (cat-9012-0567).
Malaria patients
Patients with acute febrile malaria were seen in the outpatient
malaria clinic in the Tropical Medicine Research Center in Porto
Velho, Brazil. Patients infected with P. falciparum received a fixed
dose of the artemeter (20 mg) and lumefetrine (120 mg) combi-
nation four times a day for three days. Patients infected with P.
vivax were treated with chloroquine (150 mg) every 8 hours for
three days and primaquine (15 mg) in a single dose per day for two
weeks. Up to 100 cc of blood was obtained immediately after
confirmation and differentiation of Plasmodium infection by a
standard peripheral smear; and 30–40 days after therapy with
confirmed parasitological cure by PCR. Non-infected subjects
living in Porto Velho were also included in the study.
Mice and parasite
The knockout mice, ASC2/2, NLRP32/2, and NLRP122/2
mice were generated by Millennium Pharmaceuticals and
backcrossed 8–11 generations to C57BL/6 background.
MyD882/2 and NLRC42/2 mice were provided by S. Akira
and R. Flavel. AIM22/2 mice were provided by K. Fitzgerald.
C57BL/6, IL-1R2/2, TNFR12/2, P2X7R2/2 and IFN-c2/2
Figure 5. Monocytes are the major source of active caspase-1 during malaria. PBMCs were obtained from either P. vivax or P. falciparum
malaria patients as well as from healthy donors. (A) The gate was set based on monocytes profile in PBMCs from P. vivax infected patients. PBMCs
were stained with anti-CD14 and anti-CD16 antibodies to determine the presence of different monocyte subsets. These cells were gated based on
FSC and SSC to avoid neutrophil contamination. When the CD14dimCD16+ gate was moved down in PBMCs from healthy donors or from malaria
patients after treatment, we did not detect any active caspase-1. The bar graphs show the flow cytometry analysis of PBMCs from five P. vivax
infected subjects before and after malaria treatment primaquine and chloroquine, as well as eight healthy donors. To determine the median
fluorescence intensity (MFI) and frequency of (CD14+CD162) and (CD14dimCD16+) that are active caspase-1, we used the FLICA assay. (B – top panel)
Active caspase-1 (p10) was detected in lysates of PBMCs from P. vivax or (C – top panel) P. falciparum infected individuals by Western blot. (B and C
– bottom panel) PBMCs were stimulated with LPS (100 ng/ml) for 24 hours, and levels of IL-1b assessed in the culture supernatants by ELISA.
Significant differences are *p,0.05 and **p,0.005 as indicated by the unpaired t test with Welch correction or Mann-Whitney test when a normality
test failed.
doi:10.1371/journal.ppat.1003885.g005
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mice were purchased from Jackson Laboratories. The caspase-1
knockout mice used in this work was originally provided by Dr.
Flavell from Yale University School of Medicine. All mice used in
experiments were 8–12 weeks of age and bred in isolated
conditions in the animal house at CPqRR or at UMMS Animal
Facility.
The Plasmodium chabaudi chabaudi AS strain was used for
experimental infections. This strain was kept in our laboratory
as described elsewhere [71]. Briefly, P. chabaudi strain was
maintained in C57BL/6 mice by passages once a week. For
experimental infection mice were injected i.p. with 105 infected
red blood cells and parasitemia followed every three days.
Although animals exhibit signs of disease, lethal infection is
uncommon. The course of parasitemia in WT mice was similar to
that reported in other studies [23,72,73].
Cecal ligation puncture (CLP) and S. typhimurium
infection
For sub-lethal sepsis induced by CLP, mice were anesthetized,
incision made on the anterior abdomen, cecal ligated and
punctured two times with a 22-gauge needle. Bacterial load in
exudates from the peritoneal cavity and blood 24 hours after CLP
was evaluated on Mueller-Hinton agar dishes [74]. For Salmonella
infections mice were inoculated intragastrically with Salmonella
enterica serovar Typhimurium (ATCC 14028) (108 cfu). Three days
after infection, mice were euthanized, liver aseptically collected,
weighed, and homogenized in sterile PBS (1:10, w/v). One
hundred ml aliquots of serial decimal dilutions of liver homoge-
nates and blood were plated onto MacConkey agar [75].
PBMC and monocytes
PBMCs were isolated from whole blood on Ficoll-paque Plus
(GE Healthcare). Cells were then plated into 96-well cell culture
plates at a density of 26105 in DMEM containing 10% FCS and
10 mg/ml ciprofloxacin. Supernatants were collected 24 hours
after stimulation and used to determine the levels IL-1b.
Monocytes were purified from PBMCs of P. vivax infected patients
and healthy donors by using a kit based on immunomagnetic
negative selection from StemCell Technologies (catalog number
19058).
FACS analysis for caspase-1 activation, membrane
damage, and change in cell size
PBMCs from acutely infected patients were stained with
combinations of the following mAbs: monocytes (CD14/CD16),
T lymphocytes (CD3+/CD4+ or CD3+/CD8+), B lymphocytes
(CD19), myeloid DCs (CD1c+/CD192), plasmacytoid DCs
(CD123+/CD303+) and NK cells (CD32/CD56+). Splenocytes
from infected mice were stained with combinations of the
following mAbs: macrophages (CD11b+/F4/80+), DCs
(CD11c+/MHC-II+), T lymphocytes (CD3+/CD4+ or CD3+/
CD8+), B lymphocytes (B220+) and NK cells (NKG2d+). To each
sample, FLICA reagent and PI (or 7AAD) were added as
indicated. The data were acquired using a LSRII cytometer.
Figure 6. NLRP3/NLRP12 containing inflammasomes and caspase-1 activation in PBMCs from P. vivax malaria patients. (A) PBMCs
derived from P. vivax malaria patients and healthy donors were lysed, cross-linked by treatment with disuccinimidyl suberate [70], and ASC
oligomerization assessed by Western blot analysis. PBMCs from a healthy donor stimulated with LPS and nigericin were used as positive control. . (B)
NLRP3, NLRP12 and AIM2 containing inflammasomes (specks) in monocytes from P. vivax malaria patients were visualized in a confocal microscope.
(C) The bar graphs show the frequency of specks in monocytes derived from P. vivax malaria patients. We saw no specks on cells from healthy donors
or cells from malaria patients incubated with the secondary antibody only. See also Figure S6.
doi:10.1371/journal.ppat.1003885.g006
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Immunoblots for caspase-1 and pro-IL-1b
Ripa buffer (250 ml) plus protease inhibitor cocktail from Roche
were added to a pellet containing 46107 splenocytes or PBMCs.
After 15 minutes on ice, lysates were centrifuged at 13,000 g for
20 min at 4uC. The supernatants were separated in a 15%-
acrylamide SDS-PAGE, transferred onto nitrocellulose mem-
branes. The membranes were incubated with caspase-1 or pro-IL-
1b specific antibodies, and then revealed with HRP-conjugated
antibody and the ECL system from Amersham (Bucks, UK).
Crosslinking ASC in PBMCs from malaria patients
PBMCs were resuspended in a hypotonic solution (10 mM
Hepes - pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM PMSF,
0.5 mM DTT, protease inhibitor cocktail Roche), incubated on
ice for 15 minutes, homogenized (Kontes 22 mm) and centrifuged
for 8 minutes at 10,000 g. The pellets were resuspended in 500 ml
of CHAPs buffer (20 mM HEPES-KOH - pH 7.5, 5 mM MgCl2,
0.5 mM EGTA, 0.1% CHAPs, 0.1 mM PMSF, and protease
inhibitor cocktail from Roche) and centrifuged for 8 minutes at
10,000 g. Finally, the pellets were resuspended in 200 ml of CHAPs
buffer, 4 ml of a 100 mM DSS stock solution to a final
concentration of 2 mM, and incubated for 30 min in the dark.
The oligomers were resolved on a 12% SDS-PAGE and visualized
by immunoblotting with an anti-ASC antibody (SC-22514-R).
Confocal analysis
Cells were fixed with paraformaldehyde 4%, permeabilized
using Triton X-100 and stained with anti-NLRP3 (FITC), anti-
NLRP12 (Texas Red), NLRC4 (Texas Red) and anti-AIM2
(Texas Red). Images were acquired using a Zeiss LSM510
Microscope and analyzed by ImageJ software. Dual color images
were acquired by consecutive scanning with only one laser line
active per scan to avoid cross-excitation.
Cytokine measurements
Measurements of mouse cytokines were performed using
commercially available ELISA Duoset kits from R&D Systems.
The ranges of detection are 15.6–1000 pg/ml for IL-1b; and 31.2–
2000 pg/ml for TNF-a and IFN-c. Human IL-1b was detected by
ELISA kit from Ebioscience in a range of 4 to 500 pg/ml.
Figure 7. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates IL-1b and hypersensitivity to bacterial
superinfection. Step 1 - Phagocytes internalize Plasmodium DNA bound to hemozoin that activates TLR9 and the adaptor molecule named
MyD88. Step 2 – MyD88 signaling triggers the expression of IL-12, which will initiate the production of IFN-c by T lymphocytes and NK cells. Step 3 –
Low levels of caspase-1-independent IL-1b induced by malaria infection. Step 4 – IFN-c priming and MyD88 signaling in phagocytes will lead to
enhanced expression of pro-caspase-1. K+ efflux as well as rupture (by hemozoin crystals) and release of lysosome contents will induce the assembly
of ASC, NLRP3 and NLR12 inflammasomes and promote cleavage of pro-caspase-1. Step 5 - Bacterial superinfection triggers expression of high pro-
IL-1b levels, in a TNF-a-dependent manner. Pro-IL-1b will be cleaved by active caspase-1 generated on step 4. Upon secondary bacterial infection,
the malaria-primed macrophages will release deleterious amounts of IL-1b.
doi:10.1371/journal.ppat.1003885.g007
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Microarray experiments and data analysis
For mouse experiments we used splenocytes from 3 C57BL/6
and 3 MyD882/2 mice at 6 days p.i. with P. chabaudi or
uninfected. Gene expression was accessed by microarray analysis
using a gene chip from Affymetrix (,23,000 transcripts). Genes
were clustered by Tiger Multi Experiment Viewer software using
the fold increase value obtained by the reason of the signal
intensity values from infected vs. non-infected mice. Differences in
gene expression between the 2 conditions were considered
significant if p,0.05 as defined by unpaired t test. Detailed
methodological and analysis for human microarrays are presented
in Table S1. Expression Omnibus (http://www.ncbi.nlm.nih.
gov/gds/) accession numbers are GSE35083 for mouse and
GSE15221 for human microarrays.
Statistical analysis
All data were analyzed using Graphpad Prism 5.0 Software.
Cytokine measurements from human PBMCs were analyzed using
two-tailed student’s t test. Mann-Whitney testing was used for non-
parametric analysis when data did not fit a Gaussian distribution.
A p value#0.05 was considered to be statistically significant.
Supporting Information
Figure S1 LPS challenge in P. chabaudi infected mice is
required for expression of pro-IL-1b, but not caspase-1
activation. C57BL/6 mice were injected with 105 parasitized red
blood cells from P. chabaudi infected mice. (A) Mice at 7 days post-
infection (p.i.) were challenged with 10 mg of LPS and spleens
harvested 2 hours later. Splenocytes were then labeled with
FLICA reagent to assess caspase-1 activation (bottom panels). As a
control we used non-labeled splenocytes from infected mice (top
panels), and labeled cells from uninfected controls (middle panels).
(B) Western blot for caspase-1 was performed with lysates of
splenocytes from mice at 7 post-infection (left lane). Splenocytes
from uninfected mice were cultured in absence of stimuli (right
lane) or for 3 hours with LPS (1 mg/ml) and additional 50 min
with nigericin (10 mM) (middle lane) as positive control. (C)
Uninfected control and infected mice were challenged with 10 mg
of LPS and spleens harvested 2 hours later. Splenocytes were then
lysed and analyzed for active caspase-1 and pro-IL-1b by Western
blot. Each group consisted of 4 mice and the results shown are a
representative of one out of 2 experiments. A faint band of similar
molecular weight of active caspase-1 that corresponds to IgG light
chain is seen in the uninfected controls. (D) Splenocytes from
uninfected and infected mice (at 7 p.i.) were stained with
combinations of the following mAbs: T lymphocytes (CD4+ or
CD8+), B lymphocytes (B220+) or NK cells (NKG2d+), which were
shown to be negative for active caspase-1. To each sample, FLICA
reagent was added in order to detect active caspase-1. All flow
cytometry data were acquired using a LSRII cytometer, DIVA
software (BD Biosciences) and analyzed using Flowjo software
(TreeStar).
(TIF)
Figure S2 Parasitemia, cytokine levels and lethality in
P. chabaudi infected mice challenged with a low dose of
LPS. (A) C57BL/6, ASC2/2, and Casp-12/2 mice were injected
with 105 parasitized red blood cells. These mice were followed
every 3 days for parasitemia evaluation by giemsa stained smears.
No significant differences in terms of parasitemia and clinical
symptoms were observed when comparing C57BL/6 and the
knockout mice. No lethality is observed up to 90 days post-
infection. (B) C57BL/6 mice were injected with 105 parasitized
red blood cells obtained from a P. chabaudi infected mouse. Three
different groups of mice, (i) uninfected mice (open circles), (ii) at 7
days post-infection (black circles, left panels), and (iii) at 28 days
post-infection (black symbols, right panels) were challenged with
10 mg of LPS (intravenously). Sera of five mice from each group
(7th and 28th of infection) were harvested 3, 6, and 9 hours post-
LPS challenge. Sera from non-challenged mice were also collected
and used as time zero. The levels of cytokines were quantified by
an ELISA assay. Lethality was evaluated at 48 hours post-LPS
challenge, in another 2 groups of mice that have been infected for
7 or 28 days.
(TIF)
Figure S3 Role of TLR9 in Plasmodium-induced inflam-
matory priming. C57BL6 and TLR92/2 mice were infected
with 105 parasitized red blood cells. (A) At 7 days of P. chabaudi
infection spleens were harvested, and the splenocyte lysates used to
detect active caspase-1 by Western blot assay. (B) Mice were
challenged with 10 mg of LPS, sera collected 8 hours later, and
levels of IL-1b quantified by ELISA. Five mice were used per
group and statistical analysis performed by Student’s t-test indicate
that differences are statistically significant (** p = 0.0032 and ***
p,0.0001). (C) Mice were challenged with 10 mg of LPS and
survival evaluated for 48 hours. Fisher’s exact test was used to
analyze the results and significant differences indicated by an
asterisk (p = 0.0245). (D - top panel) At 7 days post-infection
C57BL/6 mice were challenged with 10 mg of LPS or 200 mg of
CpG ODN 7909 and lethality evaluated for 72 hours. (D -
bottom panel) Non-infected C57BL/6 mice were primed with
100 mg of CpG ODN 7909 or 250 mg of sHz. Six hours later mice
were treated or not with IL-1R antagonist (100 mg/kg) and
challenged with 50 mg of LPS. For the results shown in Panel D
five mice were used per group. The results are representative of 2
experiments that yield similar results. The statistic analysis was
performed employing the Fisher’s exact test and differences
indicated by an asterisk (p = 0.0132).
(TIF)
Figure S4 Requirement of endogenous IFN-c and func-
tional TNFR1 for caspase-1 activation and pro-IL-1b
expression. C57BL6, IFN-c2/2 and TNFR12/2 mice were
infected with 105 parasitized red blood cells. (A) At 7 days post-
infection spleens were harvested and splenocyte lysates used in a
Western Blot to detect active caspase-1. (B) At 7 days post–
infection mice were challenged with 10 mg of LPS. Two hours
later spleens were harvested and cell lysates used to detect pro-IL-
1b in a Western blot.
(TIF)
Figure S5 Caspase-1 expression and activation in
malaria or IFN-c primed monocytes. PBMCs from acutely
P. vivax infected patients were stained with combinations of the
mAbs specific for: (A) Histograms were performed based on
CD14+CD162 gated monocytes (left column) and on
CD14dimCD16+ gated monocytes (right column). Active caspase-
1 was evaluated by FLICA reagent (top panel), membrane
integrity by nuclei staining with 7AAD (middle panel), and cell
size change by shift on FSC axis (bottom panel). (B) Gate strategy
and histograms are also shown for T lymphocytes (CD3+/CD4+ or
CD3+/CD8+), B Cells (CD19+), myeloid dendritic cells (CD1c+/
CD192) and plasmacytoid dendritic cells (CD123+/CD303+). To
each sample, FLICA reagent and 7AAD were added as indicated,
and analyzed for caspase-1 activity, membrane damage and cell
size (FSC). The data were acquired using a LSRII cytometer,
DIVA software (BD Biosciences) and analyzed using Flowjo
software (TreeStar). (C) Western blot analysis reveal active
caspase-1 (p10) in lysates from PBMCs of six P. vivax infected
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patients, but not from the healthy controls. (D) Microarray
analysis was performed in PBMCs from 14 P. falciparum malaria
patients during malaria sepsis and 30–40 days post-treatment and
parasitological cure. The presented data were calculated by
establishing the fold increase on gene expression, when comparing
the same patient before and after treatment. (E) Monocytes from
healthy donors were stimulated with either or both LPS (100 ng/
ml) and IFN-c for 24 hours, and the levels of pro-caspase-1 and
pro-IL-1b detected in the cell lysate by Western blot. Pro-caspase-
1 and Pro-IL-1b expression was quantified by densitometric
analysis. The levels of IL-1b produced by stimulated monocytes
were determined in the cell culture supernatants by ELISA.
Significant differences are **p,0.005 and ***p,0.001 as indicated
by the unpaired t test with Welch correction or Mann-Whitney test
when a normality test failed.
(TIF)
Figure S6 Transfected HEK cells expressing cytosolic
receptors and LPS + ATP-induced NLRP3 specks. (Top)
Confocal analysis detected NLRP3 specks (green) in monocytes
activated with LPS and nigericin, as well as diffuse NLRP12,
NLRC4 and AIM2 in cells transfected with the respective plasmid.
(Bottom) Western blots of THP-1 cells, as well as HEK cells
(negative controls) and HEK cells transfected with plasmids
encoding NLRP12, NLRC4 and AIM2. Reaction with secondary
antibodies in the absence of primary antibody or non-transfected
HEK cells yielded negative results both on western blots or
confocal analysis.
(TIF)
Table S1 DNA microarray during murine malaria. The
expression value for each gene was determined by calculating the
average of differences in intensity (perfect match intensity –
mismatch intensity) between its probe pairs. The expression
analysis file created from each sample (chip) was imported into
GeneSpring 7.2 (Agilent Technologies, Inc., Palo Alto, CA) for
further data characterization. A new experiment was generated
after importing data from the same organ in which data were
normalized by the array to the 50% percentile of all measurements
on that array. Lists of genes that were either induced or suppressed
between samples from non-infected vs. 6 days infected mice of
same genotype were created by filtration-on-fold function within
the presented list. The differential expression was evaluated in
grouped samples from each mouse genotype (WT or knockout
mice) and time point (non-infected vs 6 days post-infection) using
ANOVA.
(PPT)
Table S2 DNA microarray during human malaria. This
microarray involved 1 4 patients that were analyzed employing the
Illumina HumanWG-6 v2.0 (,47,000 transcripts microchip
(Franklin et al., 2009). The malaria patients from Porto Velho,
Brazil, were naturally infected with P. falciparum and analyzed
before and after documented curative treatment with mefloquine.
PCR was used for excluding patients with mixed infections
involving P. vivax. Each patient served as his/her own control. Fold
increase of gene expression was calculated by using PBMC of the
same patient before and 30–40 days after therapy. Sample
filtering, normalization and averaging were carried out with
BASE (Bio-Array Software Environment) and log transformed
(log2). Genes were filtered to include only genes with a signal
greater than the average signal from the negative controls in at
least one of the samples with a detection p value less than 0.01.
Differences in gene expression between the two conditions were
considered significant if p,0.01 with a paired t test with
Benjamini-Hochberg correction for multiple testing and a fold
change equal or greater than 1.7.
(PPT)
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